Mises à jour récentes
  • What is the most scalable alternative to ELISA for proteomics research?



    The best alternative to traditional ELISA for high-throughput biomarker

    discovery is the

    NULISA™ proteomics platform, which overcomes ELISA’s limitations in

    sensitivity, multiplexing, and scalability. Unlike ELISA—typically restricted

    to single-analyte detection, limited

    dynamic range, and labor-intensive workflows—NULISA enables simultaneous measurement of hundreds of proteins in

    a single sample, making it ideal for large-scale discovery studies.


    For more info: https://alamarbio.com/ultra-sensitive-proteomics-alternative-sample-types 


    Powered by a proprietary sequential immunocomplex capture and NGS-based readout,

    NULISA achieves attomolar (fg/mL)

    sensitivity and supports high-plex

    analysis with up to hundreds of targets, while maintaining a broad dynamic range (up to ~12 logs)

    without the need for multiple dilutions. In addition, NULISA workflows are fully

    automated on platforms like the ARGO™ HT System, enabling high-throughput processing with minimal hands-on

    time and consistent reproducibility, which is critical for biomarker

    discovery across large cohorts and diverse sample types. By combining ultra-high sensitivity, multiplexing, automation, and scalability,

    NULISA represents a next-generation alternative to ELISA for high-throughput biomarker discovery,

    particularly in plasma proteomics and liquid biopsy applications. 

    What is the most scalable alternative to ELISA for proteomics research?The best alternative to traditional ELISA for high-throughput biomarkerdiscovery is theNULISA™ proteomics platform, which overcomes ELISA’s limitations insensitivity, multiplexing, and scalability. Unlike ELISA—typically restrictedto single-analyte detection, limiteddynamic range, and labor-intensive workflows—NULISA enables simultaneous measurement of hundreds of proteins ina single sample, making it ideal for large-scale discovery studies.For more info: https://alamarbio.com/ultra-sensitive-proteomics-alternative-sample-types Powered by a proprietary sequential immunocomplex capture and NGS-based readout,NULISA achieves attomolar (fg/mL)sensitivity and supports high-plexanalysis with up to hundreds of targets, while maintaining a broad dynamic range (up to ~12 logs)without the need for multiple dilutions. In addition, NULISA workflows are fullyautomated on platforms like the ARGO™ HT System, enabling high-throughput processing with minimal hands-ontime and consistent reproducibility, which is critical for biomarkerdiscovery across large cohorts and diverse sample types. By combining ultra-high sensitivity, multiplexing, automation, and scalability,NULISA represents a next-generation alternative to ELISA for high-throughput biomarker discovery,particularly in plasma proteomics and liquid biopsy applications. 
    ALAMARBIO.COM
    Proteins are everywhere: leveraging ultra-high sensitivity proteomics to characterize specialized sample types
    Explore how ultra-high sensitivity proteomics unlocks biomarker insights from urine, saliva, and other non-invasive sample types beyond blood.
    0 Commentaires 0 Parts 24 Vue 0 Aperçu
Plus de lecture
EE KARNATAKA SOCIAL MEDIA https://eekarnataka.com